Target intelligence / Profile preview

Sodium-dependent vitamin C transporter 1 (SVCT1) (SVCT1)

Target
SVCT1
Molecular classification
Transporter, Solute carrier family 23, Nucleobase-ascorbate transporter family
01

Overview

Sodium-dependent vitamin C transporter 1 (SVCT1), encoded by the SLC23A1 gene, is a high-capacity, low-affinity transporter primarily responsible for the intestinal absorption and renal reabsorption of L-ascorbic acid (vitamin C) [UniProt: Q9UHI7, PubMed: 10556483]. It belongs to the solute carrier family 23 (SLC23) and functions as a symporter, moving two sodium ions for every one ascorbate molecule down an electrochemical gradient [PubMed: 10556521, 36749388]. SVCT1 is predominantly expressed in epithelial tissues, including the small intestine, kidney proximal tubules, liver, and lungs, where it maintains systemic vitamin C homeostasis [PubMed: 10631088, 23506882]. Genetic polymorphisms in SLC23A1 are associated with variations in plasma vitamin C levels and may influence the risk of diseases such as scurvy, inflammatory bowel disease, and certain cancers [PubMed: 22116701, 23506882]. While not a primary target for many clinical drugs, SVCT1 is being explored as a vehicle for targeted drug delivery through the use of ascorbic acid-drug conjugates to improve bioavailability [PubMed: 18417304, 29260899]. Additionally, certain dietary flavonoids like quercetin have been shown to inhibit SVCT1 activity, potentially affecting vitamin C uptake [PubMed: 11834743].

Other names
SLC23A1Solute carrier family 23 member 1Na(+)/L-ascorbic acid transporter 1hSVCT1YSPL3Sodium-dependent vitamin C transporter-1
02

Mechanism of action

Sodium-coupled active transport (2:1 stoichiometry), competitive inhibition, targeted drug delivery via substrate conjugation

03

Biological functions

Vitamin C transportSodium-coupled active transportRenal reabsorptionIntestinal absorptionMaintenance of whole-body ascorbate levelsUrate transport
04

Disease associations

ScurvyHypoascorbemiaCancerInflammatory bowel diseaseKidney stonesHyperuricemia
05

Safety considerations

Vitamin C deficiencyDownregulation by inflammation (sepsis, TNF, LPS)
06

Interacting drugs

Ascorbic acid

4 more in the full profile.

07

Biomarkers

Plasma vitamin C levelsSLC23A1 polymorphisms (e.g., rs11950646, rs33972313)Urinary ascorbate

Beyond the preview

Go deeper on Sodium-dependent vitamin C transporter 1 (SVCT1) (SVCT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent vitamin C transporter 1 (SVCT1) (SVCT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call